Glucocorticoid Priming of Nonviral Gene Delivery to hMSCs Increases Transfection by Reducing Induced Stresses
Human mesenchymal stem cells (hMSCs) are under study for cell and gene therapeutics because of their immunomodulatory and regenerative properties. Safe and efficient gene delivery could increase hMSC clinical potential by enabling expression of transgenes for control over factor production, behavior...
Main Authors: | Andrew Hamann, Tyler Kozisek, Kelly Broad, Angela K. Pannier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120301637 |
Similar Items
-
Comparison of promoter, DNA vector, and cationic carrier for efficient transfection of hMSCs from multiple donors and tissue sources
by: Tyler Kozisek, et al.
Published: (2021-12-01) -
High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells
by: Tyler Kozisek, et al.
Published: (2020-05-01) -
Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications
by: Andrew Hamann, et al.
Published: (2019-01-01) -
The role of surface chemistry-induced cell characteristics on nonviral gene delivery to mouse fibroblasts
by: Kasputis Tadas, et al.
Published: (2012-09-01) -
Comparison of different kinds of nonviral vectors for gene delivery to human periodontal ligament stem cells
by: Yajing Wang, et al.
Published: (2015-12-01)